how many f zero games are there
SentinelOne: Should Be Able To Maintain Expertise In Several Cybersecurity Niches
STILLWATER — For 11 years, Oklahoma State coach Mike Gundy found himself noticing Kody Walterscheid’s family on the pre-game march into Boone Pickens Stadium. “I noticed the mom's holding a baby,” Gundy said. “I'm guessing that's a grandkid. They're in the same place on The Walk, and it just happens that when I get to a certain point, that for whatever reason, I can see them. Obviously, his dad's like 6-foot-9, so it's not hard to miss them. ... That family's been a big part of our football team." Saturday’s senior day game against Texas Tech will be Walterscheid’s 61st game as a Cowboy. It will also mark the end of the 11-year streak of OSU teams including a Walterscheid that began when Kody’s older brother Cole Walterscheid joined the team in 2014. At least 20 seniors will say goodbye to Boone Pickens Stadium on Saturday, but the list could get much bigger. Twelve seniors have the option to return but might choose to go ahead and participate in senior day this weekend perhaps influenced by pending roster cuts following the season. Then there’s any players who might choose to declare early for the NFL Draft which Gundy expects to include running back Ollie Gordon and linebacker Nick Martin although he hadn't received official word yet. People are also reading... Sooners legend Tiare Jennings 'a game changer' as OU softball graduate assistant Bill Haisten: ‘Why would you even say that?’ OSU fund-raising was damaged by Gundy comments Berry Tramel: Kevin Wilson makes a decision for TU's future that might not be his State Department of Education bought 532 Trump Bibles, purchase order shows QB commit Jett Niu's dreams led him to OSU, but he had one question for Mike Gundy What's the latest with Michael Fasusi? An update on OU's top 2025 recruiting target Roster cuts are coming to Oklahoma State and Mike Gundy is dreading it Will Brent Venables make a solid offensive coordinator hire? Joe C believes so — and here's why POLL CLOSED: Vote for the Bill Knight Automotive high school football player of the week for Week 11 A new name coming for one of Tulsa's tallest buildings What's Brent Venables telling recruits now? Has no-visit policy for OU commits changed? Police, sheriff talk about what Trump's mass deportation plan could mean for Tulsa James Franco visits Outsiders House Museum Mike Gundy preparing to send Ollie Gordon, Nick Martin, Collin Oliver to NFL Draft Video: Stephen Colbert counts Ryan Walters among 'far-right weirdos' Trump could hire Sixteen seniors have played their entire career at OSU. Only five other teams in the nation have more this season. “Those guys have, a lot of them have been here for six years, and each year when they depart, I can't decide whether I think they just got here or if they've been here forever with all the classes that are meshing nowadays,” Gundy said. “These guys have won a lot of games. ... Their commitment to the organization has been very special, like all of them. It takes a lot, and those guys have been very successful.” At times, defensive lineman Collin Clay thought he’d never make it to this moment after tearing the same ACL in back-to-back years. “I felt like after my second one, I was ready to, you know, just hang it up,” Clay said. “But, you know, I just feel like I'm strong enough to just go out there and persevere through that stuff. And I feel like I did. I feel like that's a story for anybody else that may be going through the same thing. ... If you feel like you know your faith is there, just trust and believe God that everything will work out the way they're supposed to.” Clay said his time on the sidelines taught him that there’s more to life than football. At some point, his identity became completely wrapped up in the sport, which made things difficult when he couldn’t play. “It definitely built my character,” Clay said. Clay plans to coach high school football after his playing career wraps up, but he’s also considering another path— culinary school. “I think it's cool to just watch people cook things,” Clay said. “It's pretty entertaining just to see like the process and everything that it takes. ... It is just cool to be able to try new things.”
None
JPMorganChase Declares Common Stock Dividend
What we can VERIFY about Trump’s plan to use the military to support mass deportations
WASHINGTON (AP) — President-elect Donald Trump has promised to end birthright citizenship as soon as he gets into office to make good on campaign promises aiming to restrict immigration and redefining what it means to be American. But any efforts to halt the policy would face steep legal hurdles. Birthright citizenship means anyone born in the United States automatically becomes an American citizen. It's been in place for decades and applies to children born to someone in the country illegally or in the U.S. on a tourist or student visa who plans to return to their home country. It's not the practice of every country, and Trump and his supporters have argued that the system is being abused and that there should be tougher standards for becoming an American citizen. But others say this is a right enshrined in the 14th Amendment to the Constitution, it would be extremely difficult to overturn and even if it's possible, it's a bad idea. Here's a look at birthright citizenship, what Trump has said about it and the prospects for ending it: What Trump has said about birthright citizenship During an interview Sunday on NBC’s “Meet the Press” Trump said he “absolutely” planned to halt birthright citizenship once in office. “We’re going to end that because it’s ridiculous,” he said. Trump and other opponents of birthright citizenship have argued that it creates an incentive for people to come to the U.S. illegally or take part in “birth tourism,” in which pregnant women enter the U.S. specifically to give birth so their children can have citizenship before returning to their home countries. “Simply crossing the border and having a child should not entitle anyone to citizenship,” said Eric Ruark, director of research for NumbersUSA, which argues for reducing immigration. The organization supports changes that would require at least one parent to be a permanent legal resident or a U.S. citizen for their children to automatically get citizenship. Others have argued that ending birthright citizenship would profoundly damage the country. “One of our big benefits is that people born here are citizens, are not an illegal underclass. There’s better assimilation and integration of immigrants and their children because of birthright citizenship,” said Alex Nowrasteh, vice president for economic and social policy studies at the pro-immigration Cato Institute. In 2019, the Migration Policy Institute estimated that 5.5 million children under age 18 lived with at least one parent in the country illegally in 2019, representing 7% of the U.S. child population. The vast majority of those children were U.S. citizens. The nonpartisan think tank said during Trump’s campaign for president in 2015 that the number of people in the country illegally would “balloon” if birthright citizenship were repealed, creating “a self-perpetuating class that would be excluded from social membership for generations.” What does the law say? In the aftermath of the Civil War, Congress ratified the 14th Amendment in July 1868. That amendment assured citizenship for all, including Black people. “All persons born or naturalized in the United States and subject to the jurisdiction thereof, are citizens of the United States and of the State wherein they reside,” the 14th Amendment says. “No State shall make or enforce any law which shall abridge the privileges or immunities of citizens of the United States.” But the 14th Amendment didn't always translate to everyone being afforded birthright citizenship. For example, it wasn't until 1924 that Congress finally granted citizenship to all Native Americans born in the U.S. A key case in the history of birthright citizenship came in 1898, when the U.S. Supreme Court ruled that Wong Kim Ark, born in San Francisco to Chinese immigrants, was a U.S. citizen because he was born in the states. The federal government had tried to deny him reentry into the county after a trip abroad on grounds he wasn’t a citizen under the Chinese Exclusion Act. But some have argued that the 1898 case clearly applied to children born of parents who are both legal immigrants to America but that it's less clear whether it applies to children born to parents without legal status or, for example, who come for a short-term like a tourist visa. “That is the leading case on this. In fact, it’s the only case on this,” said Andrew Arthur, a fellow at the Center for Immigration Studies, which supports immigration restrictions. “It’s a lot more of an open legal question than most people think.” Some proponents of immigration restrictions have argued the words “subject to the jurisdiction thereof” in the 14th Amendment allows the U.S. to deny citizenship to babies born to those in the country illegally. Trump himself used that language in his 2023 announcement that he would aim to end birthright citizenship if reelected. So what could Trump do and would it be successful? Trump wasn't clear in his Sunday interview how he aims to end birthright citizenship. Asked how he could get around the 14th Amendment with an executive action, Trump said: “Well, we’re going to have to get it changed. We’ll maybe have to go back to the people. But we have to end it.” Pressed further on whether he'd use an executive order, Trump said “if we can, through executive action." He gave a lot more details in a 2023 post on his campaign website . In it, he said he would issue an executive order the first day of his presidency, making it clear that federal agencies “require that at least one parent be a U.S. citizen or lawful permanent resident for their future children to become automatic U.S. citizens.” Trump wrote that the executive order would make clear that children of people in the U.S. illegally “should not be issued passports, Social Security numbers, or be eligible for certain taxpayer funded welfare benefits.” This would almost certainly end up in litigation. Nowrasteh from the Cato Institute said the law is clear that birthright citizenship can’t be ended by executive order but that Trump may be inclined to take a shot anyway through the courts. “I don’t take his statements very seriously. He has been saying things like this for almost a decade," Nowrasteh said. "He didn’t do anything to further this agenda when he was president before. The law and judges are near uniformly opposed to his legal theory that the children of illegal immigrants born in the United States are not citizens." Trump could steer Congress to pass a law to end birthright citizenship but would still face a legal challenge that it violates the Constitution. __ Associated Press reporter Elliot Spagat in San Diego contributed to this report. Rebecca Santana, The Associated Press
New RapidDeploy app's video allows 911 responders to see, hear what's happening at emergency scenes
Peak U.S. Exceptionalism?Playoff game at Ohio State has sold 34% more tickets than Notre Dame game on StubHubExperience the chaos, brutality and intrigue of the realistic world of the late Middle Ages.Henry, a young man seeking justice for his murdered parents, embarks on an epic adventure where his conscience, morality and integrity are put to the ultimate test.As blood feuds and political conspiracy unfold, Henry's choices will shape his destiny. Fortune favours the brave – but every decision has a price.Kingdom Come: Deliverance II arrives February 4, 2025 on PC, Xbox Series X|S and PlayStation 5.
Stock market today: Wall Street wavers at the start of a holiday-shortened week
Christmas is almost here, and it’s the perfect time to spread joy and festive cheer through WhatsApp status updates. If you’re searching for the ideal Christmas video to set as your status, we’ve got you covered! Here’s a simple guide to help you download and share your favourite Christmas videos using two quick methods: dedicated websites and YouTube downloads. Option 1: Using a Dedicated Website A convenient way to find and download Christmas videos is by visiting websites that offer free content tailored for WhatsApp statuses. These platforms often provide festive-themed videos in high-quality formats. Follow these steps to get started: Search for “Christmas WhatsApp status videos” using your preferred search engine. Explore websites like Pinterest, Pexels, or other festival-focused content hubs. These sites usually have well-organised Christmas-themed sections for easy browsing. Select your favourite Christmas video or photo from the list. Click the download button to save it to your device. Make sure the file is in a WhatsApp-compatible format like MP4 for videos. Option 2: Downloading from YouTube YouTube offers a treasure trove of Christmas-themed videos, from animated greetings to traditional holiday messages. Here’s how to download your favorite video: Open YouTube and search for “Merry Christmas 2024 WhatsApp status video.” Browse the wide variety of options available. Once you find a video you like, click on “Share” and select “Copy Link.” Head to a YouTube downloader site or app, paste the copied link, and choose a format such as MP4 for download. Save the video to your device and upload it to your WhatsApp status to share the holiday spirit with your loved ones. With these two easy methods, you can quickly find and share the perfect Merry Christmas video to brighten your WhatsApp status. Spread love, joy, and warmth this holiday season by connecting with your friends and family through these delightful Christmas updates. Get Latest News Live on Times Now along with Breaking News and Top Headlines from Technology Science and around the world.Chargers QB Justin Herbert does not practice because of left ankle injuryStingray Acquires Loupe Art to Enhance Connected TV and Digital Signage Offerings
Camposol Holding PLC Announces Management Updates: Ricardo Naranjo appointed Chief Executive Officer.LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces the study update and interim analysis results from the Company’s COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) will be presented at the 35 th International Symposium on ALS/MND held December 6-8, 2024 in Montreal, Canada. The highlights of the presentation, titled, “ COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Interim Analysis Results” ( Abstract # 302), include: Study Update: As of November 15, 2024, a total of 217 participants have been enrolled and 183 participants were assigned to either MN-166 or placebo group. Pre-defined interim analysis was conducted to evaluate the correlation between the 6-month and 12-month data and assess the 12-month double-blind phase trial design. A subset of patients from the full analysis set who had ALSFRS-R data at 6 months and at least one post-6-month data point. Correlation analysis of the Combined Assessment of Function and Survival (CAFS) scores at 6 and 12 months as well as modified CAFS scores and ALSFRS-R scores were evaluated. Positive correlations were observed between the 6-month and 12-month data for CAFS score (0.71), modified CAFS score (0.70), and ALSFRS-R (0.69). [Note: Values in parentheses are Spearman Rank Correlation coefficients] Positive correlations were also observed for Bulbar score (0.74), Fine motor score (0.71), and Gross motor score (0.67), but not for Respiratory score. [Note: Values in parentheses are Spearman Rank Correlation coefficients] Interim analysis results were reviewed and validated by an external independent Data Safety Monitoring Board (DSMB), which recommended that the trial continue as per the protocol. MediciNova CMO and Director Kazuko Matsuda commented, "The interim analysis showed a positive correlation between the 6-month and 12-month data. We considered a change in the treatment period, decided to continue the trial with the current treatment plan based on the DSMB's recommendation. We believe these results will be valuable in designing studies for rapidly progressing diseases like ALS. As of mid-November 2024, over 200 patients have been enrolled and more than 180 patients assigned, if we continue to actively enroll in the COMBAT-ALS study, we expect to complete patient assignments by June 2025 with trial results expected in 2026. Concurrently, we have been supporting continued treatment for those patients wishing to continue MN-166 treatment after the 6-month open-label phase via the FDA's Expanded Access Program (EAP). Next year, the NIH-funded, large-scale Expanded Access Program trial is set to begin, and we look forward to the opportunity to provide access to MN-166 to more ALS patients.” About MN-166 (ibudilast) MN-166 (ibudilast) is a small molecule compound that inhibits phosphodiesterase type-4 (PDE4) and inflammatory cytokines, including macrophage migration inhibitory factor (MIF). It is in late-stage clinical development for the treatment of neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), progressive MS (multiple sclerosis), and DCM (degenerative cervical myelopathy); and is also in development for glioblastoma, Long COVID, CIPN (chemotherapy-induced peripheral neuropathy), and substance use disorder. In addition, MN-166 (ibudilast) was evaluated in patients that are at risk for developing acute respiratory distress syndrome (ARDS). About MediciNova MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic, and neurodegenerative diseases. Based on two compounds, MN-166 (ibudilast) and MN-001 (tipelukast), with multiple mechanisms of action and strong safety profiles, MediciNova has 11 programs in clinical development. MediciNova’s lead asset, MN-166 (ibudilast), is currently in Phase 3 for amyotrophic lateral sclerosis (ALS) and degenerative cervical myelopathy (DCM) and is Phase 3-ready for progressive multiple sclerosis (MS). MN-166 (ibudilast) is also being evaluated in Phase 2 trials in Long COVID and substance dependence. MN-001 (tipelukast) was evaluated in a Phase 2 trial in idiopathic pulmonary fibrosis (IPF) and a second Phase 2 trial in non-alcoholic fatty liver disease (NAFLD) is ongoing. MediciNova has a strong track record of securing investigator-sponsored clinical trials funded through government grants. Statements in this press release that are not historical in nature constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding the future development and efficacy of MN-166, MN-001, MN-221, and MN-029. These forward-looking statements may be preceded by, followed by, or otherwise include the words "believes," "expects," "anticipates," "intends," "estimates," "projects," "can," "could," "may," "will," "would," “considering,” “planning” or similar expressions. These forward-looking statements involve a number of risks and uncertainties that may cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause actual results or events to differ materially from those expressed or implied by these forward-looking statements include, but are not limited to, risks of obtaining future partner or grant funding for development of MN-166, MN-001, MN-221, and MN-029 and risks of raising sufficient capital when needed to fund MediciNova's operations and contribution to clinical development, risks and uncertainties inherent in clinical trials, including the potential cost, expected timing and risks associated with clinical trials designed to meet FDA guidance and the viability of further development considering these factors, product development and commercialization risks, the uncertainty of whether the results of clinical trials will be predictive of results in later stages of product development, the risk of delays or failure to obtain or maintain regulatory approval, risks associated with the reliance on third parties to sponsor and fund clinical trials, risks regarding intellectual property rights in product candidates and the ability to defend and enforce such intellectual property rights, the risk of failure of the third parties upon whom MediciNova relies to conduct its clinical trials and manufacture its product candidates to perform as expected, the risk of increased cost and delays due to delays in the commencement, enrollment, completion or analysis of clinical trials or significant issues regarding the adequacy of clinical trial designs or the execution of clinical trials, and the timing of expected filings with the regulatory authorities, MediciNova's collaborations with third parties, the availability of funds to complete product development plans and MediciNova's ability to obtain third party funding for programs and raise sufficient capital when needed, and the other risks and uncertainties described in MediciNova's filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2023 and its subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Undue reliance should not be placed on these forward-looking statements, which speak only as of the date hereof. MediciNova disclaims any intent or obligation to revise or update these forward-looking statements. INVESTOR CONTACT : David H. Crean, Ph.D. Chief Business Officer MediciNova, Inc [email protected]
This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site. Read this article for free: Already have an account? To continue reading, please subscribe: * This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site. Read unlimited articles for free today: Already have an account? This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site. ___ Author: Elizabeth Steyn, Assistant Professor of Law, Faculty of Law, University of Calgary The debate around deep seabed mining has been gaining attention as concerns mount about its potential impacts on ocean ecosystems. The ocean is host to countless species yet to be discovered, some of which could hold the key to breakthroughs in medicine. The impacts of deep seabed mining on ocean biodiversity are still uncertain. At worst, we face losing species without ever knowing them. For instance, one type of mining targets hydrothermal mounds, which are known to be unique ecosystems filled with extremophiles — sea life that has adapted to extreme conditions of heat and toxicity to thrive. It has long been known, then, that deep seabed mining is potentially bad news for ocean life. But deep seabed mining proponents use the language of “necessary sacrifice” to argue that the energy transition “will require trade-offs” for access to the necessary metals. This juxtaposition of biodiversity and the energy transition is a half-truth. While the climate and biodiversity crises are intertwined, we should beware of pitting one against the other. Yet this is exactly what proponents of deep seabed mining are doing. Into this fray come two recent studies published by Planet Tracker, a non-profit think tank focused on sustainable finance. In Race to the Bottom, Planet Tracker concludes that countries would receive minimal financial benefits from deep seabed mining. Mining for Trouble cautions that deep seabed mining would entail huge losses for mining economies. Before delving into the economics of deep seabed mining, it would be useful to understand where the demand is coming from. Energy transition 101 The basic building blocks of the energy transition are critical minerals. These are also known as critical energy transition minerals or critical raw materials. Battery metals such as nickel, cobalt, copper and manganese are particularly important, as they are used to power electric vehicles. With electric vehicle adoption expected to surge by 2040, demand for battery metals is projected to rise dramatically, which will likely lead to an increase in mining. According to the International Energy Agency, clean energy technology minerals are set to triple by 2030 and quadruple by 2040 in a net-zero energy scenario. But the accessible ores of many metals have already been mined. As a result, land-based mining is becoming more technically complex, geographically remote or complicated for other reasons. ‘Battery in a rock’ On the abyssal plains of the deep seabed, there are billions of tons of polymetalic nodules — metal-dense nodes containing nickel, cobalt, copper and manganese. Deep seabed mining organization The Metals Company has dubbed them “a battery in a rock” and plans to begin mining operations in the Clarion Clipperton Zone of the Pacific Ocean in June 2025. To date, issues raised about deep seabed mining mostly concern the lack of a governing regulatory framework, as well as uncertainties about its environmental, ecological and biodiversity impacts. Economic and social risk estimates have mainly focused on impacts to coastal communities who depend on fishing for their livelihoods. The recent Planet Tracker studies change this by highlighting the economic impacts of deep seabed mining. Economic impacts of deep seabed mining Deep seabed mining presents a number of financial challenges. One concern is the potential impact on metal prices. Flooding the metals markets with ocean-mined metals would likely drive down the price of the metals, which would impact the financial viability of the land-based mines that are currently producing them. There are also doubts about the demand for these metals in the quantities predicted. Battery technology is advancing rapidly, with alternatives like lithium iron phosphate batteries — used in 40 per cent of electric vehicles sold in 2023 — eliminating the need for cobalt and nickel. Emerging sodium-ion batteries are set to remove the need for copper. The financial benefits to the International Seabed Authority — an international organization that regulates mining in most of the world’s oceans — would also be marginal. Projections estimate that annual royalties distributed among member countries to the United Nations Convention on the Law of the Sea (UNCLOS) would range from US$42,000 to US$7.35 million. This amount reflects both deep seabed mining corporate income tax and royalties. In comparison, mining economies would lose more than US$560 billion annually in export earnings. This discrepancy arises because deep seabed minerals don’t belong to any jurisdiction and thus cannot be similarly taxed. Regulatory hurdles To obtain exploration licences for deep seabed mining, UNCLOS requires member states to sponsor a mining operator. While sponsoring states can impose royalties on operators, some arrangements, such as those involving The Metals Company and Nauru, are part of agreements that include no corporate income tax. This, Planet Tracker cautions, can give rise to a “race to the bottom” where member states vie to give operators the most favourable terms. Sponsoring states also face financial risks and can find themselves liable for large amounts when they can least afford it. Papua New Guinea, for example, was left to cover AU$157 million when Nautilus Minerals collapsed. Finally, the financial viability of deep seabed mining itself is questionable. Even if profitable, the environmental remediation costs for deep seabed mining could exceed the value of any metals mined — and the damage may not even be reversible. These financial and ecological concerns paint a bleak picture. Our oceans fulfil an important planetary role, both in terms of climate and in terms of biodiversity. Should we really disturb this balance with deep seabed mining when the numbers don’t even add up? ___ Elizabeth Steyn previously received funding from the United Nations Environment Programme (UNEP). She is affiliated with the Prospectors and Developers Association of Canada (PDAC), the Canadian Institute of Mining, Metallurgy and Petroleum (CIM) and the Natural Resources Law Teachers Institute (NRLTI). She is a board member of the Canadian Institute of Resources Law (CIRL), a Fellow of the Centre for Military, Security and Strategic Studies (CMSS) and an International Committee Member of the Foundation for Natural Resources and Energy Law (FNREL). ___ This article is republished from The Conversation under a Creative Commons license. Disclosure information is available on the original site. Read the original article: https://theconversation.com/deep-seabed-mining-bad-for-biodiversity-and-terrible-for-the-economy-243893 Advertisement AdvertisementChargers QB Justin Herbert does not practice because of left ankle injuryHydrogen Generation Market to grow by USD 49.7 Billion from 2024-2028, driven by fertilizer demand and AI-driven market transformation - TechnavioThe huge rally for U.S. stocks lost momentum on Thursday as Wall Street counted down to a big jobs report that’s coming on Friday. The crypto market had more action, and bitcoin briefly burst to a record above $103,000 before pulling back. The S&P 500 slipped 0.2% from the all-time high it had set the day before, its 56th of the year so far, to shave a bit off what’s set to be one of its best years of the millennium. The Dow Jones Industrial Average fell 248 points, or 0.6%, while the Nasdaq composite slipped 0.2% from its own record set the day before. Bitcoin powered above $100,000 for the first time the night before, after President-elect Donald Trump chose Paul Atkins, who’s seen as a crypto advocate, as his nominee to head the Securities and Exchange Commission. The cryptocurrency has climbed dramatically from less than $70,000 on Election Day, but it fell back as Thursday progressed toward $99,000, according to CoinDesk. Sharp swings for bitcoin are nothing new, and they took stocks of companies enmeshed in the crypto world on a similar ride. After rising as much as 9% in early trading, MicroStrategy, a company that’s been raising cash just to buy bitcoin, swung to a loss of 4.8%. Crypto exchange Coinbase Global fell 3.1% after likewise erasing a big early gain. Elsewhere on Wall Street, stocks of airlines helped lead the way following the latest bumps up to financial forecasts from carriers. American Airlines Group soared 16.8% after saying it’s making more in revenue during the last three months of 2024 than it expected, and it will likely make a bigger profit than it had earlier forecast. The airline also chose Citi to be its exclusive partner for credit cards that give miles in its loyalty program. That should help its cash coming in from co-branded credit card and other partners grow by about 10% annually. Southwest Airlines climbed 2% after saying it’s seeing stronger demand from leisure travelers than it expected. It also raised its forecast for revenue for the holiday traveling season. On the losing end of Wall Street was Synposys, which tumbled 12.4%. The supplier for the semiconductor industry reported better profit for the latest quarter than analysts expected, but it also warned of “continued macro uncertainties” and gave a forecast for revenue in the current quarter that fell short of some analysts’ estimates. American Eagle Outfitters fell even more, 14.3%, after the retailer said it’s preparing for “potential choppiness” outside of peak selling periods. It was reminiscent of a warning from Foot Locker earlier in the week and raised more concerns about how resilient U.S. shoppers can remain. Solid spending by U.S. consumers has been one of the main reasons the U.S. economy has avoided a recession that earlier seemed inevitable after the Federal Reserve hiked interest rates to crush inflation. But shoppers are now contending with still-high prices and a slowing job market. This week’s highlight for Wall Street will be Friday’s jobs report from the U.S. government, which will show how many people employers hired and fired last month. A report on Thursday said the number of U.S. workers applying for unemployment benefits rose last week but remains at historically healthy levels. Expectations are high that the Fed will cut its main interest rate again when it meets in two weeks. The Fed began easing its main interest rate from a two-decade high in September, hoping to offer more support for the job market. In the bond market, the yield on the 10-year Treasury edged down to 4.17% from 4.18% late Wednesday. The S&P 500 fell 11.38 points to 6,075.11. The Dow sank 248.33 to 44,765.71, and the Nasdaq composite lost 34.86 to 19,700.26. In stock markets abroad, indexes were mostly calm in Europe after far-right and left-wing lawmakers in France joined together to vote on a no-confidence motion that will force Prime Minister Michel Barnier and his Cabinet to resign. The CAC 40 index in Paris added 0.4%. In South Korea, the Kospi fell 0.9% to compound its 1.4% decline from the day before. President Yoon Suk Yeol was facing possible impeachment after he suddenly declared martial law on Tuesday night. He revoked the martial law declaration six hours later. Crude oil prices slipped after eight members of the OPEC+ alliance of oil exporting countries decided to put off increasing oil production. ___ AP Business Writers Yuri Kageyama and Matt Ott contributed. The Nov. 29 print edition of The Business Journal included The huge rally for U.S. stocks lost momentum on Thursday Eli Lilly is spending another $3 billion to bulk up Known across the globe as the stuck astronauts, Butch Wilmore